Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.44 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | F12 | P00748 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | PLAT | P00750 | 1/20 | 0.44 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
| ▸ | HPN | P05981 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.44 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438965 | 0.86 | PRSS1 (0.50) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL27142282 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL13292705 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL28723326 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL6868914 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL23272065 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL28724455 | 0.81 | KMT2A (0.59) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 | |
| SCHEMBL10301409 | 0.80 | ELANE (0.40) | KMT2ACYP1A2MAPTALDH1A1LMNA | |
| SCHEMBL16261997 | 0.80 | KMT2A (0.51) | KMT2AMAPTALDH1A1LMNAHTT | |
| SCHEMBL16270507 | 0.80 | MAPT (0.62) | KMT2ACYP1A2MEN1SLC22A2TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8552139-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-8552139-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | KMT2A 4078/4885CYP1A2 749/4885MEN1 3028/4885 |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | KMT2A 4078/4885CYP1A2 749/4885MEN1 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.